Vitamin D3 Does Not Improve Cardiovascular, Cancer Outcomes
The VITAL randomized clinical trial tested vitamin D and marine omega-3 fatty acid supplements in the primary prevention of cancer and cardiovascular disease.
The VITAL randomized clinical trial tested vitamin D and marine omega-3 fatty acid supplements in the primary prevention of cancer and cardiovascular disease.
Treatment with an SGLT2 inhibitor may help patients with CKD or type 2 diabetes better preserve their kidney function.
The association is revealed in a study of more 444,000 US veterans with new-onset chronic kidney disease.
In a study of patients with stage 4 chronic kidney disease and poorly controlled blood pressure, chlorthalidone significantly decreased systolic blood pressure compared with placebo.
Patients with moderate and severe infection experienced a 17.50% and 23.16% decrease in estimated glomerular filtration rate (eGFR), respectively, from baseline (before testing positive for SARS-CoV-2) to 90 days after the positive test.
Analysis of United Network for Organ Sharing data reveals a declining trend in patients receiving a kidney from a living donor from 2010 to 2019.